LESLIE JUMP: Open Payments
NPI 1063718237 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 50 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,293 · 2025 $1,039
Food & beverage: $947Education: $76Consulting: $16
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $195 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Genentech USA, Inc. | 5 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $68 |
| BioCryst US Sales Co., LLC | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Ionis Pharmaceuticals, Inc. | 2 | $54 |
| Pharming Healthcare, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $42 |
Products named: DUPIXENT, NEFFY, Xolair, CUVITRU, TEZSPIRE, ORLADEYO, RUCONEST, PANZYGA.
Industry payments across OK — which companies pay providers there.
